261 related articles for article (PubMed ID: 24548444)
1. [Hypermethylation of CpG island in promoter region of MEIS1 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
Jia JS; Spicuglia S
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3835-40. PubMed ID: 24548444
[TBL] [Abstract][Full Text] [Related]
2. [Methylation of CpG island in promoter region of RUNX2 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
Jia JS; Salvatore S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):273-8. PubMed ID: 23628015
[TBL] [Abstract][Full Text] [Related]
3. Promoter demethylation accompanies reactivation of the HOX11 proto-oncogene in leukemia.
Watt PM; Kumar R; Kees UR
Genes Chromosomes Cancer; 2000 Dec; 29(4):371-7. PubMed ID: 11066085
[TBL] [Abstract][Full Text] [Related]
4. Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia.
Li Y; Liu S; Wang H; Mai H; Yuan X; Li C; Chen X; Wen F
PLoS One; 2017; 12(3):e0173472. PubMed ID: 28278270
[TBL] [Abstract][Full Text] [Related]
5. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.
Zheng S; Ma X; Zhang L; Gunn L; Smith MT; Wiemels JL; Leung K; Buffler PA; Wiencke JK
Cancer Res; 2004 Mar; 64(6):2000-6. PubMed ID: 15026336
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
8. G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia.
Riz I; Hawley RG
Oncogene; 2005 Aug; 24(36):5561-75. PubMed ID: 15897879
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia.
Goodman PA; Burkhardt N; Juran B; Tibbles HE; Uckun FM
Oncogene; 2003 Apr; 22(16):2504-14. PubMed ID: 12717427
[TBL] [Abstract][Full Text] [Related]
10. The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumors.
Dihal AA; Boot A; van Roon EH; Schrumpf M; Fariña-Sarasqueta A; Fiocco M; Zeestraten EC; Kuppen PJ; Morreau H; van Wezel T; Boer JM
PLoS One; 2013; 8(11):e79898. PubMed ID: 24244575
[TBL] [Abstract][Full Text] [Related]
11. A microarray model system identifies potential new target genes of the proto-oncogene HOX11.
Hoffmann K; Dixon DN; Greene WK; Ford J; Taplin R; Kees UR
Genes Chromosomes Cancer; 2004 Dec; 41(4):309-20. PubMed ID: 15384172
[TBL] [Abstract][Full Text] [Related]
12. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
16. [Expression and Promoter CpG Island Methylation Status of miR-34b in Leukemia Cell Lines and Their Clinical Significance].
Guo JX; Zhou YH; Guan RT; Pan JX; Zhang XY; Zhong JF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1235-9. PubMed ID: 26524015
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia.
Hütter G; Kaiser M; Neumann M; Mossner M; Nowak D; Baldus CD; Gökbuget N; Hoelzer D; Thiel E; Hofmann WK
Leuk Res; 2011 May; 35(5):614-9. PubMed ID: 21156323
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.
Shiramizu B; Mick P
Med Pediatr Oncol; 2003 Dec; 41(6):527-31. PubMed ID: 14595709
[TBL] [Abstract][Full Text] [Related]
19. Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax.
Li D; Yuan Y; Meng C; Lin Z; Zhao M; Shi L; Li M; Ye D; Cai Y; He X; Ye H; Zhou S; Zhou H; Gao S
Clin Epigenetics; 2024 Mar; 16(1):48. PubMed ID: 38528641
[TBL] [Abstract][Full Text] [Related]
20. Multiple negative elements contribute to repression of the HOX11 proto-oncogene.
Brake RL; Kees UR; Watt PM
Oncogene; 1998 Oct; 17(14):1787-95. PubMed ID: 9778044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
